Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease

The present findings confirmed plasma NfL as best predictor of progression in PD, with a marginal role of p-tau181 and GFAP.

Authors

Institutions

Publication Details

Journal
Journal of Neurology
Published
2024-09-09
DOI
https://doi.org/10.1007/s00415-024-12669-7
Citations
25
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
9.23

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease

Alessandro Salvi, Marina Pizzi, Elisabetta Cottini, Antonio Canale et al.
25 citations
Journal of Neurology
Parkinson's Disease Mechanisms and Treatments
9.23
article

Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease

Alessandro Salvi, Marina Pizzi, Elisabetta Cottini, Antonio Canale, Andrea Pilotto, Kaj Blennow, Beatrice Battaglio, Cinzia Zatti, Giuseppina De Petro, Stefano Gipponi, Ilaria Grossi, Alessandro Padovani, Chiara Trasciatti, Nicholas J. Ashton, Henrik Zetterberg, Alessandro Lupini
article en
25 citations

Abstract

The present findings confirmed plasma NfL as best predictor of progression in PD, with a marginal role of p-tau181 and GFAP.

Journal of NeurologyVol. 271(12)
University of Science and Technology of China (CN), University of Wisconsin–Madison (US), University of Padua (IT), King's College London (GB), Sahlgrenska University Hospital (SE), Centre for Mental Health (GB), Sorbonne Université (FR), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT), Pitié-Salpêtrière Hospital (FR), UK Dementia Research Institute (GB), Institut du Cerveau (FR), University College London (GB), University of Brescia (IT), University of Gothenburg (SE)
Office of Dietary Supplements, Alzheimer's Drug Discovery Foundation, Familjen Erling-Perssons Stiftelse, Stiftelsen för Gamla Tjänarinnor, EU Joint Programme – Neurodegenerative Disease Research, National Institute for Health and Care Research, University College London, European Commission, Ministero della Salute, Ministero dell’Istruzione, dell’Università e della Ricerca, Hjärnfonden, Vetenskapsrådet, Università degli Studi di Brescia, UK Dementia Research Institute, Associazione Italiana Ricerca Alzheimer, National Institutes of Health, Horizon 2020 Framework Programme, UCLH Biomedical Research Centre, H2020 European Research Council, H2020 Marie Skłodowska-Curie Actions, HORIZON EUROPE Reforming and enhancing the European Research and Innovation system
Good health and well-being
Openalex Percentile: Top 1%
Parkinson's Disease Mechanisms and Treatments
9.23
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.